Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|June 27, 2009
A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapseAnjali Advani, Tao Jin, Brian Bolwell, et al.
Blood|October 4, 2008
Aberrant DNA methylation is a dominant mechanism in MDS progression to AMLYing Jiang, Andrew Dunbar, Lukasz P Gondek, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 17, 2013
Ribosomal S6 kinase and AKT phosphorylation as pharmacodynamic biomarkers in patients with myelodysplastic syndrome treated with RAD001Anjali S Advani, Reda Z Mahfouz, Jaroslaw Maciejewski, et al.
Ejhaem|December 5, 2022
Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemiaTerrence Bradley, Deukwoo Kwon, Jorge Monge, et al.
Leukemia Research|October 12, 2007
Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AMLAnjali S Advani, Cristina Rodriguez, Tao Jin, et al.
Infection Control and Hospital Epidemiology|August 8, 2012
Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignanciesMegan J Digiorgio, Cynthia Fatica, Mary Oden, et al.
Leukemia & Lymphoma|September 4, 2008
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemiaAnjali S Advani, Tao Jin, Giridharan Ramsingh, et al.
BMC Cancer|July 29, 2010
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patientsAnjali S Advani, Sarah E Gibson, Elizabeth Douglas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methodsWael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
British Journal of Haematology|March 8, 2011
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)Anjali S Advani, Sarah Gibson, Elizabeth Douglas, et al.
Pageof 3